Q&A: Focus on myelodysplastic syndromes
A growing incidence of myelodysplastic syndromes (MDS), mostly in older adults, has sent researchers and clinicians scrambling for...
Q&A: Minimally invasive surgery for cancer patients
Just a few years ago, most surgeries were "open," or invasive, procedures in which a surgeon made a large incision while the surgery...
Q&A: Cardiac catheterization for cancer patients
A cardiac catheterization laboratory contains specialized technology that benefits cancer patients when they need more thorough...
Q&A: Intravenous busulfan before stem...
The invention of IV Busulfex™ (the intravenous formulation of busulfan) has contributed to a dramatic change in the standard of care for patients undergoing stem cell transplantation for leukemia. It also has greatly improved the outlook for patients with hematologic (blood) and lymphoid cancers.
In March, the lead inventor, Borje S. Andersson, M.D., Ph.D., professor in MD Anderson's Department of Stem Cell Transplantation...
Q&A: Proton therapy for pediatric patients
Anita Mahajan, M.D., associate professor in Radiation Oncology, answers questions about proton therapy for pediatric cancer...
Race and ethnicity as cancer risk factors
As we acknowledge National Minority Cancer Awareness Week, it's an appropriate time to pause to look at why race and ethnicity might...
Q&A: Thyroid cancer
Thyroid cancer is a disease in which cancer cells are found in the tissue of the thyroid gland.
Camilo Jimenez, M.D., assistant...
MD Anderson in Istanbul, Turkey
Vehbi Koc Foundation (VKF) American Hospital and MD Anderson recently announced that they are expanding cancer care services in...